摘要
目的:通过分析micro RNA-208在急性心肌梗死(acute myocardial infarction,AMI)患者外周血中含量的变化,探讨micro RNA-208在AMI疾病进展中的作用。方法:连续性收集2013年1月~2013年12月滁州市第一人民医院心血管内科和急诊科收治的急性心肌梗死(AMI)患者42例,不稳定心绞痛(unstable angina,UA)患者22例,健康体检志愿者20名,荧光定量PCR测定外周血micro RNA-208的含量,电化学发光法检测血浆c Tn I和CK-MB的水平。AMI组患者根据不同冠脉病变支数和接受急诊经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗进行分组,对比各组患者外周血micro RNA-208水平的差异。结果:AMI患者外周血micro RNA-208的水平显著高于UA组和健康对照组,差异具有统计学意义(P〈0.01),AMI患者外周血micro RNA-208的水平与血清CTn I含量呈正相关(r=0.700,P=0.000)。24例行冠状动脉造影术的AMI组患者中,micro RNA-208的表达在两支及三支病变中高于单支病变(P〈0.01),17例成功接受急诊PCI治疗的AMI患者,其症状发作后的24h血浆micro RNA-208水平较入院即刻时明显降低(P〈0.01)。结论:心肌细胞特异性的micro RNA-208在心肌梗死后外周血含量明显升高,随着血管狭窄严重程度的升高其浓度也显著变化,可以作为辅助监测急性心肌梗死的敏感的生物学指标。
Objective: To study the change of cardio-specific microRNA-208 levels in acute myocardial infarction patients and to explore the effect of microRNA-208 levels on the diagnosis of AMI. Methods: The consecutive subjects in roll in this study, including 42 patients with AMI, 22 patients with UA and 40 healthy subjects in our hospital from January 2013 to December 2013, microRNA-208 concentrations were measured with real-time reverse- transcription PCR, all the clinical data of patients was collected. AMI patients were further divided into subgroups according to coronary arteries involved and primary PCI or not, Plasma microRNA-208 concentrations were analyzed. Serum Cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) concentrations were measured. Results: microRNA-208 expression was significantly higher in the AMI patients than that in the UA patients group and healthy controls immediately after admission (P〈0.01). The Plasma microRNA-208 in the patients with AMI had a positive correlation with serum cTnI (P〈0.01). MicroRNA-208 levels in AMI patients with two- and three-vessel coronary artery disease (CAD) were significantly higher than those in patients with single vessel CAD (P〈0.05). microRNA-208 level at admission was significantly higher than that 24h after PCI in AMI patients (P〈0.01). Conclusion: The circulation miRNA-208 was found to be linearly to myocardial damage and may prove to be a newbiomarker of AMI.
出处
《临床与病理杂志》
CAS
2015年第4期648-652,共5页
Journal of Clinical and Pathological Research
基金
无锡市医院管理中心医学科技项目(YGM1119)~~